British Society for Haematology 59thAnnual Scientific Meeting

Share on: 
April 1 to April 3, 2019
United Kingdom

RTI Health Solutions researcher Matthew Cawson will be presenting research on treatments for acute myeloid leukemia at the upcoming British Society for Haematology Annual Scientific Meeting.

Cost-effectiveness of gemtuzumab ozogamicin in combination with standard of care chemotherapy (daunorubicin and cytarabine) for first-line treatment of acute myeloidleukaemia. Mokgokong R, Mamolo C, Cappelleri J, Knight C, Brockbank J, Cawson M, Dombre H, Castaigne S. 

Poster Number: BSH19-PO-015
Location: Halls 1&2 - Exhibition Hall
Viewing: Monday, 1 April
Poster Moderation Session: Tuesday, 2 April, 18:15 - 19:15 

If you would like to arrange a meeting with Matthew during the conference, click here



Related Services:
Conference participants: